Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/120040
Title: | The therapeutic potential of migrastatin-core analogs for the treatment of metastatic cancer |
Author: | Giralt Lledó, Ernest Lo Re, Daniele |
Keywords: | Metàstasi Càncer Productes naturals Metastasis Cancer Natural products |
Issue Date: | 9-Feb-2017 |
Publisher: | MDPI |
Abstract: | Tumor metastasis is a complex process in which cells detach from the primary tumor and colonize a distant organ. Metastasis is also the main process responsible for cancer-related death. Despite the enormous efforts made to unravel the metastatic process, there is no effective therapy, and patients with metastatic tumors have poor prognosis. In this regard, there is an urgent need for new therapeutic tools for the treatment of this disease. Small molecules with the capacity to reduce cell migration could be used to treat metastasis. Migrastatin-core analogs are naturally inspired macrocycles that inhibit pathological cell migration and are able to reduce metastasis in animal models. Migrastatin analogs can be synthesized from a common advanced intermediate. Herein we present a review of the synthetic approaches that can be used to prepare this key intermediate, together with a review of the biological activity of migrastatin-core analogs and current hypotheses concerning their mechanism of action. |
Note: | Reproducció del document publicat a: https://doi.org/10.3390/molecules22020198 |
It is part of: | Molecules, 2017, vol. 22, num. 198 |
URI: | http://hdl.handle.net/2445/120040 |
Related resource: | https://doi.org/10.3390/molecules22020198 |
ISSN: | 1420-3049 |
Appears in Collections: | Articles publicats en revistes (Química Inorgànica i Orgànica) Articles publicats en revistes (Institut de Recerca Biomèdica (IRB Barcelona)) Publicacions de projectes de recerca finançats per la UE |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
668981.pdf | 5.64 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License